Tailored Breast Cancer Screening

| | Health Imaging | Screening

Tuesday, Nov. 27, 4:30-6:00 p.m. | N227

Experts discuss the impact of the revision of the U.S. Preventive Services Task Force screening mammography guidelines in 2009, the role of screening MR for high-risk women and the use of screening breast ultrasound for women with dense breasts.

Speaker Information:

  • Daniel B. Kopans, MD, Harvard Medical School, Boston
  • D. David Dershaw, MD, Memorial Sloan-Kettering Cancer Center, New York City
  • Stephen Albert Feig, MD, University of California, Los Angeles

Related Content

AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.